Talkspace is the largest in-network telehealth mental health provider in the US, benefiting from strong demand and a scalable, flexible clinician model. The strategic shift to a payor model has driven rapid revenue growth, improved profitability, and created a more attractive, affordable consumer offering. Financials are robust: 15%+ revenue growth, strong operating leverage, GAAP profitability, a fortress balance sheet, and active share buybacks support the investment case.

CNBC's Becky Quick reports on the latest news.

I rate IDEXX Laboratories a buy, driven by a lasting surge in pet ownership and IDXX's leadership in veterinary diagnostics. New platforms like inVue Dx and Cancer Dx provide additional growth drivers, with strong early adoption and potential for margin expansion. IDXX's recurring revenue model, robust retention, and expanding high-margin consumables base support sustained revenue and earnings growth.

DURHAM, N.C., July 17, 2025 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading fully integrated site organization, has announced a strategic partnership with Palantir Technologies (“Palantir”) to automate and streamline the notoriously complex payments reconciliation process in clinical trials.

Hyatt Hotels Corporation stock (NYSE: H) has experienced a robust performance lately, increasing by 10% over the last month, surpassing the broader S&P 500's 3% return and competitor Marriott International's (NASDAQ: MAR) 7% rise. However, after such a rally, the critical question is: what comes next?

- Proven In-Office, Repeatable, Non-Surgical Procedure for the Targeted Delivery of a Wide Variety of Therapies for Serious Retinal Diseases -

NORWALK, Conn. , July 17, 2025 /PRNewswire/ -- Terex Corporation (NYSE: TEX) will host a conference call to review its second quarter 2025 financial results on Thursday, July 31, 2025 at 8:30 a.m.

Ivanhoe Electric (IE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Oil rebounded on strong demand signals and easing trade tensions, boosting XOP and SLX while pressuring XRT, CRAK, JETS, and GDX.

Roblox is starting age-estimation technology for users who want to chat more freely on the social-gaming platform as part of its new "trusted connections" feature. Chief Safety Officer Matt Kaufman said the move coincides with "features that we really believe are something that should be limited to an older audience — 13 and over.

Miami, FL, July 17, 2025 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced it will release financial results for the second quarter 2025 before the market opens on Thursday, August 7, 2025. Management will host a webcast and conference call that same day at 10:00 a.m. Eastern time to review the Company's results.

I focus on wide-moat, growth-driven, financially robust companies trading below fair value, following Buffett's simplicity philosophy for long-term investing. Salesforce, ASML, and Equinix each lead their industries, benefit from strong secular trends, and offer sustainable dividend growth with low payout ratios. All three boast investment-grade credit ratings and robust balance sheets and are currently trading at attractive discounts to fair value estimates.

ROCKVILLE, Md., July 17, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that it entered into a definitive agreement to acquire 100% ownership of Bridge Health Biotech Co., Ltd. (Bridge Health). The transaction provides I-Mab with the rights to bispecific and multi-specific applications (including bispecific and multi-specific antibodies and antibody drug conjugates (ADCs)), based on the Claudin 18.2 (CLDN18.2) parental antibody used in the Company's CLDN18.2 x 4-1BB bispecific antibody, givastomig.

FRIENDSWOOD, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has earned multiple awards through the 2025 Top Workplaces program: a third consecutive national Healthcare Industry Top Workplaces award, with Castle ranking third among other recognized companies in its size bracket; a fourth consecutive regional Arizona Top Workplaces award from AZ Central; and consecutive national Top Workplaces Culture Excellence awards for Innovation, Work-Life Flexibility, Compensation & Benefits, Leadership and Purpose & Values. “Being recognized as a Top Workplace, year after year, demonstrates …

Lantronix's new NTC-500 Series enables enterprises to achieve next-gen mobility, real-time insights and improved ROI Lantronix's new NTC-500 Series enables enterprises to achieve next-gen mobility, real-time insights and improved ROI

MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results.

GREENWICH, Conn., July 17, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) will hold its second quarter 2025 earnings conference call and webcast on Wednesday, August 6, 2025, at 8:30 a.m. Eastern Time. The company's results will be released after market close on Tuesday, August 5, 2025, and made available at that time on investors.gxo.com.

ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, will issue its second quarter 2025 financial results on Thursday, August 7, 2025 prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.

CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) ("Chicago Atlantic" or the “Company”), a commercial mortgage real estate investment trust, announced details for the release of its results for the second quarter ended June 30, 2025.

HOLLISTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced a CEO succession plan under which John Duke will assume the role of President & CEO following the planned retirement of Jim Green, effective July 28, 2025. Jim Green will be retiring from his President, CEO & Chairman roles at Harvard Bioscience after more than 8 years as Chairman and 6 years as President & CEO.